Integrating Gene Transfer Vectors With Genetic Insulator Elements
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene transfer vectors used in gene therapy often cause genotoxic side effects due to random integration into the genome, leading to unintended activation or inactivation of nearby genes, which can result in cancerous changes, as seen in clinical trials such as those for X-linked severe combined immunodeficiency (SCID-X1) and X-linked chronic granulomatous disease.
Innovation Solution
Development of integrating gene transfer vectors incorporating multiple copies of CTCF or CTF binding sites as genetic insulator elements to prevent regulatory cross-talk between the vector-encoded genes and genomic sequences, reducing the risk of genotoxicity and enhancing the stability and efficacy of gene transfer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If integrating gene transfer vectors are used to achieve stable gene transfer, then gene transfer efficacy is improved, but genotoxic side effects occur due to random integration into the genome
Solution Approach 1:
The patent introduces genetic insulator elements as intermediary sequences between the vector integration site and the transgene. These insulator elements act as protective barriers that prevent regulatory cross-talk between genomic sequences and the transgene, thereby reducing genotoxic side effects while maintaining integration-mediated stable expression. The insulator elements include specific DNA sequences such as CTCF binding sites that form chromatin boundaries.
Solution Approach 2:
The patent segments the vector construct into distinct functional regions: the integration site, the genetic insulator element, and the transgene. This segmentation allows the insulator element to be positioned specifically between the genomic integration site and the transgene, creating a buffered zone that isolates the transgene from potentially harmful genomic regulatory sequences while preserving the benefits of integration.
2Productivity
If vectors integrate randomly into the genome to achieve gene transfer, then gene transfer is achieved, but unintended activation or inactivation of nearby genes occurs
Solution Approach 1:
The genetic insulator element serves as an intermediary barrier that protects the transgene from regulatory cross-talk with neighboring genomic sequences. This intermediary sequence prevents both activation and inactivation effects from spreading across the insulator, ensuring stable and predictable transgene expression regardless of the integration location.
3Object-affected harmful factors
If genetic insulator elements are added to vectors to prevent regulatory cross-talk, then genotoxicity risk is reduced, but vector complexity increases
Solution Approach 1:
The patent extracts and utilizes specific, well-defined insulator sequences (such as CTCF binding sites) that can be independently cloned and inserted into the vector. By using discrete, characterized sequence elements rather than large insulator regions, the design minimizes the increase in vector complexity while maintaining the protective function.
Data Source
AI summary
The present invention relates to a gene transfer vector (GTV) and in particular to an integrating gene transfer vector (IGTV), which comprises at least one genetic insulator element (GIE), wherein the each comprises at least two copies of an element selected from the group consisting of: a CTF binding site; a first CTCF binding site and a second CTCF binding site, wherein the first and the second CTCF binding sites are derived from the regulatory sequences of different genes.